Dr. Berk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
133 Claybrook Rd
Dover, MA 02030Phone+1 925-719-3531
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1987 - 1990
Case Western Reserve University School of MedicineClass of 1984, MD
Certifications & Licensure
CA State Medical License 2004 - 2020
Publications & Presentations
PubMed
- 100 citationsPharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.Shannon M. Mumenthaler, Patricia Y.B. Ng, Amanda Hodge, David J. Bearss, Gregory Berk
Molecular Cancer Therapeutics. 2009-10-01 - 9 citationsSafety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemiaAli T. Taher, Antoine N. Saliba, Kevin H. Kuo, Patricia J. Giardina, Alan R. Cohen
American Journal of Hematology. 2017-09-22 - 2 citationsStaphylococcal protein A primed leukocytes enhance the autologous mixed lymphocyte reactionGregory I. Berk, Michael M. Lederman, Matthew L. Liebman, Jerrold J. Ellner
The American Journal of the Medical Sciences. 1986-04-01
Press Mentions
Chutes & Ladders—Pfizer Taps McKinsey U.S. Managing Partner as New M&a LeaderAugust 27th, 2021- GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical OfficerAugust 23rd, 2021
- GT Biopharma Reports First Quarter 2021 ResultsMay 17th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
